Gamma Knife treatment is a non-invasive procedure used to treat brain tumors. It prevents the need for open-skull neurosurgery and instead relies on up to hundreds of focused beams of radiation to precisely target a brain tumor. First invented in 1967 in Sweden by the illustrius Professor Lars Leksell, this stereotactic radiosurgery technique uses Cobalt-60 as its radiation source. The gamma rays that are emitted during the decay process are what irradiate the tumor and give the technique its name. The treatment is exciting because, according to clinical reports, patients can be in and out of treatment within a day, and back to a normal routine without the severe side effects normally associated with surgery. As innovation continues within the field of radiation oncology, the sharing of emerging research and information is important and the International Gamma Knife Research Foundation Meeting is one forum that makes it possible.
The International Gamma Knife Research Foundation Meeting is in its fourth year and serves to increase dialogue and disseminate novel information regarding the use of Gamma Knife. It is a space for radiation oncologists, neurosurgeons, researchers, and businesses to join and discuss innovation in the field. Oncora will be attending this year’s meeting, which will be held on June 23rd in Philadelphia, PA at the Perelman School of Medicine at the University of Pennsylvania. We will be presenting a live demonstration of our platform during the interactive session of the meeting and are looking forward to sharing and getting feedback from the radiation oncology and neurosurgery communities.
Using past radiation treatment regimens and outcomes data, Oncora builds predictive models that help physicians design personalized radiation treatment plans. At Oncora we encourage data sharing, as we believe the use of this data can help doctors deliver the best possible treatments to their patients. The International Gamma Knife Research Foundation is a force of positive change within the field of personalized medicine, working to push research and innovation forward and we are excited to participate in their annual meeting.